Magnussen, Gry Irene <br/><br/>
Synthetic retinoid CD437 induces apoptosis and acts synergistically with TRAIL receptor-2 agonist in malignant melanoma.  [electronic resource] 

 -  Biochemical and biophysical research communications  Apr 2012 
 - 516-22 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1090-2104 
<br/><br/><label>Standard No.: </label>10.1016/j.bbrc.2012.03.023  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal--pharmacology<br/>Antineoplastic Agents--pharmacology<br/>Apoptosis--drug effects<br/>Caspase 8--metabolism<br/>Caspase 9--metabolism<br/>Cathepsin D--metabolism<br/>Cell Line, Tumor<br/>Cell Survival--drug effects<br/>Drug Synergism<br/>Humans<br/>Melanoma--metabolism<br/>Poly(ADP-ribose) Polymerases--metabolism<br/>RNA, Messenger--biosynthesis<br/>Receptors, TNF-Related Apoptosis-Inducing Ligand--agonists<br/>Retinoids--pharmacology<br/>Skin Neoplasms--metabolism<br/>Transcription Factor CHOP--biosynthesis<br/>Up-Regulation<br/>fas Receptor--biosynthesis